靶向蛋白降解药物市场分析及建议

Market Analysis and Countermeasures for Targeted Protein Degradation Drugs

靶向蛋白降解技术兼具高活性、高选择性和靶向“不可成药”靶点等诸多优势,打破了传统治疗手段的局限性,被认为是生物医药领域的革命性技术,已发展成为目前最前沿、最有效的疾病治疗策略之一。过去20年,基于靶向蛋白降解系统的各类降解技术层出不穷,其中以分子胶、蛋白水解靶向嵌合体为代表的小分子靶向蛋白降解药物取得了突飞猛进的发展,大量临床试验评价充分证实了靶向降解蛋白质的广泛性和有效性,为一些“无药可治”的疾病带来全新的潜在治疗手段,具有极大的开发利用价值和市场潜力。为进一步推动我国靶向蛋白降解药物行业创新发展,通过定量和定性结合的分析方法,深入剖析国内外靶向蛋白降解药物行业技术和产品研发现状及市场趋势,并从未来突破方向和体制机制创新等角度提出针对性建议。

Targeted protein degradation technology breaks the limitations of traditional therapies and is considered to be a revolutionary technology in the field of biomedicine due to its high activity,high selectivity and targeting of“undruggable”targets.It has developed into one of the most cutting-edge and effective disease treatment strategies.In the past two decades,various degradation technologies based on targeted protein degradation systems have been emerging.Among them,small molecule targeted protein degradation drugs,represented by molecular glues and proteolysis-targeting chimeras,have made rapid progress.A large number of clinical trials and evaluations have fully confirmed the universality and effectiveness of targeted protein degradation.The technology brings new potential treatment options for some“incurable”diseases,and has great development and utilization value and market potential.In order to further promote the innovation and development of China’s targeted protein degradation drug industry,quantitative and qualitative combination of analytical methods are used in this paper to deeply analyze the current situation and market trends of technology and product research and development of targeted protein degradation drugs industry domestically and overseas.Meanwhile,targeted countermeasures are put forward from the perspective of future breakthrough direction and institutional mechanism innovation.